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Abstract
Von Hippel Lindau (Vhl) gene inactivation results in embryonic lethality. The consequences of its inactivation in adult mice,
and of the ensuing activation of the hypoxia-inducible factors (HIFs), have been explored mainly in a tissue-specific manner.
This mid-gestation lethality can be also circumvented by using a floxed Vhl allele in combination with an ubiquous
tamoxifen-inducible recombinase Cre-ER
T2. Here, we characterize a widespread reduction in Vhl gene expression in Vhl
floxed-
UBC-Cre-ER
T2 adult mice after dietary tamoxifen administration, a convenient route of administration that has yet to be fully
characterized for global gene inactivation. Vhl gene inactivation rapidly resulted in a marked splenomegaly and skin
erythema, accompanied by renal and hepatic induction of the erythropoietin (Epo) gene, indicative of the in vivo activation
of the oxygen sensing HIF pathway. We show that acute Vhl gene inactivation also induced Epo gene expression in the
heart, revealing cardiac tissue to be an extra-renal source of EPO. Indeed, primary cardiomyocytes and HL-1 cardiac cells
both induce Epo gene expression when exposed to low O2 tension in a HIF-dependent manner. Thus, as well as
demonstrating the potential of dietary tamoxifen administration for gene inactivation studies in UBC-Cre-ER
T2 mouse lines,
this data provides evidence of a cardiac oxygen-sensing VHL/HIF/EPO pathway in adult mice.
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Introduction
The ability of cells to respond to low O2 supply (hypoxia) is
fundamental in numerous pathological scenarios [1]. Hypoxia-
inducible transcription factors (HIF) 1a,2 a and 3a, prolyl
hydroxylase domain proteins (PHDs) 1, 2 and 3 and the von
Hippel-Lindau (VHL) protein are essential molecular elements in the
cellular response to low O2 supply. In normoxia, PHDs hydroxylate
prolyl residues in the HIFa subunits that are then recognized by
VHL, a protein of the multiprotein E3 ubiquitin ligase complex that
marks them for degradation by the proteasome [2,3]. In conditions of
hypoxia O2 is limited and it is insufficient to hydroxylate prolyl
residues in HIFa [4,5]. As a result, these HIFa isoforms are stabilized
and form a heterodimer with the HIFb subunit, promoting the
expression of many genes involved in cellular adaptation to hypoxia
[6]. This includes the expression of erythropoietin (Epo)i nt h ek i d n e y
and liver in order to facilitate oxygen delivery to hypoxic tissues
[7,8,9,10]. Global Vhl gene inactivation in mice, and the ensuing HIF
activation, can be used as a strategy to explore hypoxia signalling in
vivo. However, conventional global Vhl gene inactivation is lethal in
embryos [11], although this can be circumvented by only inducing
Vhl gene inactivation in adult mice.
Widespread and acute gene inactivation in adult mice can be
achieved through the ubiquitous expression of an inducible Cre
recombinase, which can be used to eliminate the Vhl allelic region
flanked by two loxP sites (a floxed Vhl allele). The nuclear activity
of Cre can be induced by fusing it to a mutant form of the human
estrogen receptor (ER
T2) that does not recognize its natural ligand
(17b-estradiol) at physiological concentrations but rather, it binds
the synthetic estrogen receptor ligand 4-hydroxytamoxifen (4-HT)
[12]. This Cre-ER
T2 is retained in the cytoplasm and only enters
the nucleus in the presence of 4-HT, where it binds to loxP sites of
the corresponding floxed alleles. Like other ubiquitous promoters,
widespread Cre-ER
T2 expression can be achieved in mice using
the human ubiquitin C (UBC) promoter (UBC-Cre-ER
T2 mice)
[13]. Several means of administering tamoxifen have been
described in rodents, including intraperitoneal injections and
gavage [13]. However, the addition of 4-HT to powdered food or
drinking water is a more convenient and less stressful means of
inducing Cre recombinase activity in adult mice [14,15,16]. While
the administration of tamoxifen via drinking water is hampered by
its poor solubility, its delivery in food has been successfully
achieved in several mouse lines [14,15,16]. However, to date, the
full potential of a tamoxifen diet and its efficacy in inducing global
Cre-ER
T2 activity in different organs of a Cre-ER
T2 transgenic
mouse line (e.g. UBC-Cre-ER
T2 mice) has not been fully explored.
Here we have successfully employed diet-based tamoxifen
administration, a timesaving and convenient mean of delivering
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22589tamoxifen in order to induce widespread inactivation of the Vhl
gene in a Vhl
floxed-UBC-Cre-ER
T2 mouse line. After validating
the efficiency of tamoxifen dietary administration, we character-
ized VHL/HIF oxygen-sensing dependent events that were
rapidly induced by global Vhl inactivation in vivo (within just a
few days) in contrast to other works that have mainly studied the in
vivo consequences of Vhl gene inactivation over several weeks
[17,18]. This study validates the use of the tamoxifen diet in UBC-
Cre-ER
T2 mouse lines for global gene inactivation, and it identifies
an oxygen-sensing VHL/HIF pathway controlling extra-renal Epo
gene expression in cardiac tissue.
Results
Postnatal tamoxifen diet-mediated Vhl gene inactivation
Global Vhl gene inactivation results in embryonic lethality, at least in
part due to placental dysfunction [11], preventing the study of the
global loss of this gene in adult mice. We were interested in the short-
term effects of activating the oxygen-sensing HIF pathway in vivo,a sa
result of global Vhl gene inactivation in adult Vhl
floxed-UBC-Cre-ER
T2
mice through dietary tamoxifen administration. Since the full potential
of dietary tamoxifen administration for global gene inactivation has not
been explored previously, we first validated the efficacy of the
tamoxifen diet in reducing Vhl gene expression in the Vhl
floxed-UBC-
Cre-ER
T2 mouse line. Age-matched Vhl
floxed-UBC-Cre-ER
T2 as well
as control mice Vhl
floxed and Vhl
wt-UBC-Cre-ER
T2 were maintained
for 10 days on an ad libitum diet of tamoxifen pellets (containing
400 mg/kg tamoxifen), before they were switched to a diet of normal
chow for a further 10 days and Vhl gene expression was analyzed by
quantitative real-time PCR in the different mouse organs. Hereinafter,
the terms Vhl
floxed,V h l
wt-UBC-Cre-ER
T2 and Vhl
floxed-UBC-Cre-
ER
T2 r e f e rt om i c et h a th a v eb e e na d m i n i s t e r e dat a m o x i f e nd i e ta s
indicated above. The tamoxifen diet significantly reduced Vhl gene
expression in the kidney, spleen, liver, skeletal muscle, brown adipose
tissue (BAT), heart, lung and brain of Vhl
floxed-UBC-Cre-ER
T2 mice,
reflecting widespread Vhl gene inactivation (Figure 1A). No differences
in tamoxifen intake were observed between Vhl
floxed-UBC-Cre-ER
T2
and control mice (Figure 1B). Significantly, gene inactivation was not
homogeneous and expression of the Vhl gene was more strongly
downregulated in the kidney and spleen, and less so in other tissues
such as the brain and lung (Figure 1A). To further validate the
specificity of Vhl gene inactivation, we also quantified Vhl gene
expression in another UBC-Cre-ER
T2 system, the Hif1a
floxed-UBC-
Cre-ER
T2 m o u s el i n ea n dt h e i rc o r r e s p o n d i n gH i f 1 a
floxed and Hif1a
wt-
UBC-Cre-ER
T2 control mice. While there were no significant
differences in tamoxifen intake between the different lines
(Figure 1D), Hif1a gene expression was dramatically and globally
reduced, while Vhl gene expression was not affected in tamoxifen fed
Hif1a
floxed-UBC-Cre-ER
T2 mice (Figure 1C, E).
As mice were transiently exposed to a different diet, we
evaluated their body weight before and after tamoxifen treatment.
Baseline body weight diminished in a similar way (,10%) in
Vhl
floxed-UBC-Cre-ER
T2 and control mice after 10 days on the
tamoxifen diet (Figure 2). However, while the body weight of
control mice returned to pre-tamoxifen levels just one day after
switching back to a normal diet (Figure 2), that was not the case in
Vhl
floxed-UBC-Cre-ER
T2 mice following tamoxifen treatment
(Figure 2), suggesting that body weight was rapidly compromised
by Vhl gene inactivation.
Gross appearance of mice shortly after acute Vhl
inactivation
To further evaluate the efficacy of the tamoxifen diet on Vhl
gene inactivation, we studied the biological consequences of acute
Vhl inactivation soon after the mice returned to a normal diet (10
days). We evaluated spleen size and skin erythema as macroscopic
indicators of activation of the HIF oxygen-sensing pathway in vivo
[19]. All tamoxifen-treated Vhl
floxed-UBC-Cre-ER
T2 mice ana-
lyzed exhibited marked splenomegaly when compared with
controls (Figure 3 A, B). Moreover, some mice displayed obvious
reddening of their paws and snouts (Figure 3 C, D). These external
signs of skin erythema appeared as early as the ninth day of
tamoxifen administration (data not shown), suggesting that this
phenotype represents an acute manifestation of Vhl gene
inactivation. Overall, these data confirm that dietary administra-
tion of tamoxifen is an efficient and convenient mean to induce
widespread and rapid gene inactivation of floxed alleles in UBC-
Cre-ER
T2 mice and in particular, to study the short-term
biological consequences of Vhl inactivation.
Acute Vhl inactivation induces cardiac Epo gene
expression
Splenomegaly and erythema are recognized signs of activation
of the oxygen-VHL/HIF/EPO pathway, and they have been
reported previously in transgenic mice overexpressing EPO
[20,21]. Given that the kidney and liver are the main sites of
EPO production in adults [7,22,23], we investigated Epo gene
expression in these organs in Vhl
floxed-UBC-Cre-ER
T2 mice
shortly after Vhl gene inactivation. When we analyzed renal and
hepatic Epo gene expression in tamoxifen-treated Vhl
floxed-UBC-
Cre-ER
T2 mice, we found a strong induction of this gene in the
kidney (,200 fold, Figure 4A) and an even stronger increase in the
liver when compared to control mice (Figure 4B). The marked
difference between these two organs is probably due to the very
low basal levels of hepatic Epo gene expression, which results in
more marked differences when Vhl is inactivated. These
differences cannot simply be attributed to differences in Vhl
inactivation, as Vhl is inactivated to a greater extent in the kidney
than in the liver (Figure 1A). Moreover, serum EPO levels were
drastically elevated in tamoxifen-treated Vhl
floxed-UBC-Cre-ER
T2
when compared with tamoxifen-treated control mice (pg of EPO/
ml: 150.5622.6 in Vhl
floxed versus 49835.5621586 in Vhl
floxed-
UBC-Cre-ER
T2; n=4,p,0.05). These mice showed a remarkable
reticulocytosis. Indeed, the number of circulating reticulocytes as
well as splenic reticulocytes increases in Vhl
floxed-UBC-Cre-ER
T2
mice (Circulating reticulocytes x10
6/ml : 603.926437 in Vhl
floxed
versus 6391.5361381 in Vhl
floxed-UBC-Cre-ER
T2;n = 3 ,
p=0.018) (Splenic reticulocytes x10
6/ml :3 2 66.08 in Vhl
floxed versus
269.0864.4 in Vhl
floxed-UBC-Cre-ER
T2; n=3, p=0.01). How-
ever, a parallel hemocytometry showed that hematocrit is not
significantly elevated in tamoxifen-treated Vhl
floxed-UBC-Cre-
ER
T2 when compared with control mice (hematocrit %:
40.862.02 in Vhl
floxed versus 4365.3 in Vhl
floxed-UBC-Cre-
ER
T2; n=5, p=NS). Furthermore, a follow up of Vhl
floxed-
UBC-Cre-ER
T2 mice revealed that they started to show anemia
after a longer time period upon Vhl gene inactivation (hematocrit %:
42.6262.22 in Vhl
floxed versus 33.263.8 in Vhl
floxed-UBC-Cre-
ER
T2; n=7, p=0.041). In addition, the proportion of Hoechst
33342
negative CD71
negative cells decrease in the spleens of Vhl
floxed-
UBC-Cre-ER
T2 (% of total number of splenic cells: 27.1065.3 in
Vhl
floxed versus 3.2261.25 in Vhl
floxed-UBC-Cre-ER
T2;n = 3 ,
p,0.01). This possibly reflects a specific VHL-dependent effect on
mature red blood cells survival that will be further explored in
futures studies.
In line with other studies, baseline Epo gene expression was
particularly weak in the heart [8], although we found a remarkable
elevation in cardiac Epo gene expression in tamoxifen fed Vhl
floxed-
UBC-Cre-ER
T2 mice (Figure 4D). Given that cardiac Vhl
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floxed-UBC-
Cre-ER
T2 mice (Figure 1A), we presumed that cardiac Epo gene
expression could be potentially higher if Vhl deletion were more
prominent. Expression of glucose transporter-1 (Glut1), a HIF-
dependent gene [24], was also elevated in the hearts of tamoxifen
treated Vhl
floxed-UBC-Cre-ER
T2 mice (Figure 4D). In addition,
Epo gene expression was markedly upregulated in the brain
(Figure 4C), possibly reflecting oxygen-sensing VHL/HIF-depen-
dent EPO production in glial cells, as described previously [25].
Induction of Epo gene expression was stronger in cardiac tissue
than in the brain, perhaps due to the weak basal expression of the
Epo gene in the heart. These data suggest that the oxygen-sensing
VHL/HIF/EPO pathway is not restricted to classical EPO-
producing tissues, and they demonstrate that the heart can express
EPO upon Vhl inactivation. To determine whether cardiomyo-
cytes could be contributing to this VHL-dependent response, Epo
gene expression was analyzed in isolated primary rat cardiomy-
ocytes exposed to low oxygen tension. While weak basal expression
of the Epo gene was observed in normoxic cardiomyocytes,
hypoxia (1% O2) augmented markedly its expression (Figure 5A).
Likewise, Glut1 expression was also induced, which indicates an
effective induction of the HIF pathway in these experimental
conditions (Figure 5B). We further evaluated the role of the HIF
system in hypoxia-induced Epo gene expression in cardiac cells in
the HL-1 cell line, a well-recognized cardiac cell model that retains
a differentiated cardiac myocyte phenotype and maintains
contractile activity [26]. We specifically silenced expression of
Hif1a, the main HIF isoform expressed at RNA level in this
cardiomyocyte cell line (data not shown and Figure 6C). Glut1
expression was induced by hypoxia in control scramble-transfected
HL-1 cells but its expression was markedly attenuated in HL-1
cells transfected with siHIF1a (Figure 6B). Similarly, hypoxia-
induced Epo gene expression was reduced when Hif1a was silenced
in these cells (Figure 6A). These data indicate that hypoxia-
induced Epo gene expression is an autonomous VHL/HIF-
dependent cardiomyocyte response that occurs shortly after
activation of this oxygen-sensing pathway. This response provides
a molecular and cellular explanation for the elevated levels of
cardiac Epo gene expression in Vhl
floxed-UBC-Cre-ER
T2 mice.
Discussion
The oxygen-sensing VHL/HIF dependent pathway plays a
central role in cellular adaptation to oxygen fluctuations [27,28].
This role has primarily been explored in mouse models in which
HIF is chronically overactivated following tissue-specific Vhl
inactivation [22,25,29]. Here, we characterize the short-term in
vivo responses following global inactivation of Vhl in the Vhl
floxed-
Figure 2. Body weight during and after tamoxifen diet administration in Vhl
floxed-UBC-Cre-ER
T2 and control mice. Body weight of
Vhl
wt-UBC-Cre-ER
T2 (n=3), Vhl
floxed-UBC-Cre-ER
T2 (n=6) control Vhl
floxed (n=6) mice was measured before tamoxifen treatment (TFX 0d), at the end
of 10 days on a tamoxifen diet (TFX 10d) and one day after returning to a normal diet (N +1d). Statistical significance was assessed using a two-tailed
Student’s t-test, (*, p,0.05; **, p,0.01; ns, no significant differences).
doi:10.1371/journal.pone.0022589.g002
Figure 1. Vhl and Hif1a gene expression in tamoxifen-fed Vhl
floxed-UBC-Cre-ER
T2 and Hif1a
floxed-UBC-Cre-ER
T2 mice. (A) Vhl
wt-UBC-Cre-
ER
T2 (n=3), Vhl
floxed (n=6) and Vhl
floxed-UBC-Cre-ER
T2 (n=6) mice were placed on a tamoxifen diet for ten days followed by ten additional days on a
normal diet. Gene expression was assessed by RT-PCR in the tissues indicated, the expression of the Vhl gene was normalized to that of Hprt and it
was expressed as the change relative to Vhl
floxed mice. (B) Tamoxifen intake was measured over the 10 days of tamoxifen administration in Vhl
wt-UBC-
Cre-ER
T2 (n=3), Vhl
floxed (n=6) and Vhl
floxed-UBC-Cre-ER
T2 (n=6) mice. (C,E) Hif1a
wt-UBC-Cre-ER
T2 (n=4), Hif1a
floxed (n=3) and Hif1a
floxed-UBC-Cre-
ER
T2 (n=5) mice were administered tamoxifen as indicated above. Hif1a (C) or Vhl (E) gene expression was normalized to that of Hprt and expressed
as the change relative to Hif1a
floxed mice. (D) Tamoxifen intake in Hif1a
wt-UBC-Cre-ER
T2 (n=4), Hif1a
floxed (n=3) and Hif1a
floxed-UBC-Cre-ER
T2 (n=5)
mice was measured as in B. Total intake per day was expressed relative to the body weight at the end of the tamoxifen treatment and the values
represent the mean 6 SEM. Statistical significance was assessed using a two-tailed Student’s t-test, (*, p,0.05; **, p,0.01) when comparing Vhl
wt-
UBC-Cre-ER
T2 or Hif1a
wt-UBC-Cre-ER
T2 with Vhl
floxed-UBC-Cre-ER
T2 or Hif1a
floxed-UBC-Cre-ER
T2 respectively; (
##,p ,0.01) when comparing Vhl
floxed or
Hif1a
floxed with Vhl
floxed-UBC-Cre-ER
T2 or Hif1a
floxed-UBC-Cre-ER
T2 respectively.
doi:10.1371/journal.pone.0022589.g001
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T2 mouse line. For this purpose, we employed
dietary administration of tamoxifen, a timesaving and convenient
method of tamoxifen administration to induce Cre-ER
T2 activity.
The full potential for global gene inactivation was not previously
explored. Indeed, dietary administration of tamoxifen has been
characterized in mice with specific Cre-ER
T2 expression in the
heart, forebrain or in endothelial cells [14,15,16]. However, a
comparative analysis of the efficiency of tamoxifen diet in different
organs to determine its full potential to induce widespread gene
inactivation has not been performed. Moreover, some of these
studies have required several weeks on a tamoxifen diet. Here, we
describe global gene inactivation in UBC-Cre-ER
T2 mouse lines
shortly (a few days) after tamoxifen administration.
In this first place, it appears that UBC-Cre-ER
T2 is suitable to
produce global gene inactivation in animals fed with a tamoxifen
diet. However, tamoxifen-mediated Vhl gene inactivation was less
pronounced in the Vhl
floxed-UBC-Cre-ER
T2 line than Hif1a gene
inactivation in Hif1a
floxed-UBC-Cre-ER
T2 line, an effect that
could not be attributed to differences in tamoxifen intake. This
differential inactivation may reflect the specific efficacy of the Cre-
ER
T2 recombinase to act on the floxed region of the Vhl and Hif1a
alleles. Thus, optimization of the tamoxifen diet may be necessary
to achieve comparable effects in distinct UBC-Cre-ER
T2 mouse
lines. Nevertheless, the extent to which Vhl gene expression was
reduced in these mice was sufficient to induce the activation of
oxygen-sensing HIF pathways in vivo. Indeed, macroscopic
Figure 3. Gross appearance of tamoxifen-fed Vhl
floxed-Cre-ERT2 mice. (A) Vhl
wt-UBC-Cre-ER
T2 (n=3), Vhl
floxed (n=9) and Vhl
floxed-UBC-Cre-
ER
T2 (n=10) mice were administered tamoxifen as indicated in Figure 1 and the spleen/body weight ratio was then determined. Statistical
significance was assessed using a two-tailed Student’s t-test (*, p,0.05; **, p,0.01). Representative images of spleens (B), snouts (C) and paws (D) of
Vhl
floxed-UBC-Cre-ER
T2 and control Vhl
floxed mice are shown.
doi:10.1371/journal.pone.0022589.g003
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floxed-UBC-Cre-ER
T2 mice
revealed marked splenomegaly, an indicator of increased activity
of the oxygen-VHL/PHD/HIF sensing pathway, as seen in Phd2
deficient and Phd1:Phd3 double knock-out mice [19]. Tamoxifen-
treated Vhl
floxed-UBC-Cre-ER
T2 mice also rapidly show signs of
skin erythema (Figure 3). Indeed, reddening of the paws and
snouts can be apparent as early as the ninth day of tamoxifen
administration (data not shown). This could reflect an increased
blood flow to the skin as a consequence of local HIF-induced nitric
oxide (NO) release and subsequent local vasodilatation as has been
previously shown upon chronic epidermal Vhl deletion [30].
Boutin et al. also show that this increased cutaneous perfusion, as a
consequence of epidermal Vhl gene inactivation, subsequently
reduces liver/skin blood flow ratio leading to elevated hepatic Epo
Figure 4. Erythropoietin gene expression in the kidney, liver, brain and heart of tamoxifen-fed Vhl
floxed-UBC-Cre-ER
T2 mice. Vhl
wt-
UBC-Cre-ER
T2 (n=3), Vhl
floxed (n=6) and Vhl
floxed-UBC-Cre-ER
T2 (n=6) mice were administered tamoxifen as indicated in Figure 1. Gene expression
was assessed by RT-PCR in the kidney (A), liver (B), brain (C) and heart (D). The expression of Epo and Glut1 was normalized to that of Hprt and
expressed as the change relative to Vhl
floxed mice. Statistical significance was assessed using a two-tailed Student’s t-test (*, p,0.05; **, p,0.01).
doi:10.1371/journal.pone.0022589.g004
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expression observed in tamoxifen-treated Vhl
floxedUBC-Cre-ER
T2
mice is most likely a consequence of local Vhl gene deletion and
HIF2a activation in liver.
It should be noted that other similar genetic systems have been
developed to achieve inactivation of floxed alleles. Indeed, the
tetracycline-dependent (Tet) system has been used for renal-
specific Cre expression and subsequent inactivation of the
tuberous sclerosis complex-1 (Tsc-1) when doxycycline is admin-
istered in the drinking water [31]. However, some difficulties in
activating this doxycycline-dependent system in certain tissues
have been reported [32,33,34]. By contrast, gene expression is
significantly reduced in all the tissues analyzed from both Vhl
floxed-
UBC-Cre-ER
T2 and Hif1a
floxed-UBC-Cre-ER
T2 mouse lines
exposed to tamoxifen diet.
Tamoxifen-treated Vhl
floxed-UBC-Cre-ER
T2 mice have identi-
fied the heart as an additional site of EPO production upon Vhl
inactivation. Indeed, the baseline expression of the Epo gene in the
heart is weak but is elevated dramatically upon inactivation of Vhl
gene expression. Experiments on isolated neonatal rat cardiomy-
Figure 5. Erythropoietin and glucose transporter-1 gene expression in isolated primary cardiomyocytes in response to hypoxia.
Isolated rat cardiomyocyte cultures were subjected to basal normoxic conditions and/or hypoxia (1% O2) for 24 hours. Epo (A) and Glut1 (B)
expression was then analyzed by RT-PCR and normalized to that of Hprt. The data from four independent experiments are expressed as the change
relative to the normoxic values. Statistical significance was assessed using a two-tailed paired t-test (*, p,0.05).
doi:10.1371/journal.pone.0022589.g005
Figure 6. Erythropoietin and glucose transporter-1 gene expression in HL-1 cardiomyocyte cell line in response to activation of the
oxygen-sensing HIF pathway. (A,B,C) HL-1 cells were transfected with a siRNA for Hif1a (siHIF1a) or a scrambled siRNA control (siSCR) and
24 hours after transfection, the cells were exposed to normoxic or hypoxic (1% O2) conditions. The expression of Epo, Glut1 and Hif1a was measured
as described above and the data from three independent experiments are expressed as the change relative to the normoxic values. Statistical
significance was assessed using a two-tailed Student’s t-test (*, p,0.05).
doi:10.1371/journal.pone.0022589.g006
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cardiomyocyte response to hypoxia that is mediated by the
oxygen-sensing VHL/HIF pathway. This response is also
observed in the HL-1 cardiac cell line, an experimental model
suitable to study EPO production in adult cardiac cells. HL-1 is a
cardiac cell line derived from the AT-1 adult mouse atrial
cardiomyocyte tumor lineage, and these cells retain a differenti-
ated cardiac myocyte phenotype and they maintain contractile
activity [26]. Moreover, erythropoietin production has been
demonstrated after myocardial infarction [35], which on the basis
of our data could be mediated by cardiac HIF activation.
HIF1a gene expression is higher than HIF2a in HL-1 cells,
which may explain the predominant contribution of HIF1a to
hypoxia-induced Epo gene expression in these cardiac cells.
However, the relative contribution of each isoform may differ in
vivo and indeed, immunohistological studies have identified both
HIF1a and HIF2a in cardiomyocytes of mice subjected to
ischemia or atmospheric hypoxia [36,37,38,39,40]. Hif1a
floxed
m i c ee x p r e s s i n gC r ed r i v e nb ym y o s i nl i g h tc h a i n2 v( M L C 2 v )
cardiac promoter (Hif1a
floxed-MLC2v-Cre mice) markedly
reduced HIF1a mRNA and protein expression in the heart,
providing genetic evidence of Hif1a gene expression in
cardiomyocytes [36]. Several studies have demonstrated a
critical role for HIF1a in multiple cardiac oxygen-sensing
pathways in vivo [29,36,41]. Thus, HIF1a could potentially drive
cardiac Epo gene expression upon Vhl gene inactivation.
However, HIF2a is the main contributor to HIF-induced Epo
gene expression upon Vhl gene inactivation in the kidney, liver
and glial cells [22,25,42,43]. Further studies will therefore be
required to assess the relative contribution of these isoforms in
vivo, and especially that of HIF2a to VHL/HIF-dependent
cardiac EPO expression. It should be also noted that HIF1a and
HIF2a are also found in cardiac stromal cells. Indeed, cardiac
endothelial cells abundantly express both HIF isoforms when
oxygen supply to myocardium becomes limited, as do cells in
the vessel wall that are presumably smooth muscle cells,
[36,37,38,39,40]. Therefore, cardiac Epo gene expression upon
Vhl gene inactivation involves HIF activation in cardiomyocytes,
although we cannot rule out the involvement of HIF activation
in other cardiac cell types.
Elevation of cardiac Epo gene expression is very remarkable,
although it occurs to a lesser extent than in the liver and kidney.
Therefore, it is conceivable that cardiac EPO production serves a
local autocrine or paracrine function when oxygen supply to
cardiac tissue becomes limited. Indeed, several studies have shown
that EPO protects cardiac tissue during ischemia and the
ischemia-reperfusion insult, particularly by overactivating the
serine threonine kinase AKT, as well as through other pathways
involving sonic hedgehog [44,45,46]. Indeed, the myocardium of
patients undergoing bypass is protected when pyruvate, a
previously recognized suppressor of PHD activity, is used [47],
which correlates with a remarkable upregulation of Epo gene
expression [48]. However, the effect of pyruvate on Epo gene
expression was not directly assessed in cardiac cells, nor was the
direct contribution of HIF activity, as we have studied in this work.
Furthermore, cardiac tolerance to ischemic damage induced by
ischemic preconditioning in the heart involves HIF1a mediated
upregulation of key cardioprotective molecules, such as ecto-59-
nucleotidase CD73 that generates adenosine, and the A2B
adenosine receptor (A2BAR) [49]. Therefore, the cardiac
oxygen-sensing VHL/HIF/EPO pathway may represent an
endogenous cardioprotective response that works in tandem with
other pathways (e.g. adenosine) to locally induce cardiomyocyte
tolerance against ischemia or ischemia-reperfusion damage.
Materials and Methods
Ethics Statement
All the experimental procedures were approved by the Research
Ethics Committee at the UAM (Autonomous University of
Madrid) and they were carried out under the supervision of the
Head of Animal Welfare and Health at the UAM in accordance
with Spanish and European guidelines (B.O.E, 18 March 1988,
and 86/609/EEC European Council Directives).
Cell culture and hypoxic conditions
The murine HL-1 cardiac cell line was cultured in Claycomb
medium [26] containing 10% heat-inactivated Fetal Bovine Serum
(FBS: Cambrex) and supplemented with 0.1 mM norepinephrine
(Sigma) and 2 mM GLUTAMAX-I (Invitrogen). Cells were plated
on gelatin (Difco) and fibronectin (Sigma) precoated surfaces, and
cultured at 37uC for 16 hours. Neonatal rat cardiomyocytes were
isolated from the hearts of 1 day-old Wistar rats using the Neomyt
isolation system (Cellutron Life Technologies). To remove
contaminating cardiac fibroblasts, dissociated cells were pre-plated
for 1 hour on uncoated culture plates. The resulting suspension of
cardiomyocytes was plated (2–3 million cells/60 mm plate) and
cultured for 24 hours in medium supplemented with 10% FBS
and 10 mM 5-bromo-29-deoxyuridine (BrdU; Sigma, B5002), and
then for an additional 24 hours in serum-free conditions. The cells
were subjected to hypoxia in DMEM + 10% FBS. All media were
supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin
and 1% HEPES buffer. Normoxic cells (21% O2) were maintained
at 37uC in an incubator with 5% CO2. To induce hypoxia, cell
culture dishes were placed into an Invivo2 400 humidified hypoxia
workstation (Ruskinn Technologies, Bridgend, UK) with 1% O2.
Mice
C;129S-Vhlh
tm1Jae/J mice (Jackson Laboratories, stock no. 4081)
were used to generate the Vhl
floxed-UBC-Cre-ER
T2 mice. These
mice harbor two loxP sites flanking the promoter and exon 1 of the
murine Vhl locus [50]. C;129S-Vhlh
tm1Jae/J mice were crossed with
B6.Cg-Tg(UBC-Cre/ER
T2)1Ejb/J mice (Jackson Laboratories,
stock no. 008085) which ubiquitously express a tamoxifen-
inducible Cre recombinase (Cre-ER
T2), [13]. Vhl
floxed-UBC-Cre-
ER
T2 mice were generated through the appropriate crosses, along
with the corresponding controls, Vhl
wt-UBC-Cre-ER
T2 and
Vhl
floxed. Hif1a
floxed-UBC-Cre-ER
T2 mice were generated from
B6.129-Hif1a
tm3Rsjo/J mice (Jackson Laboratories, stock no.
007561), which harbor two loxP sites flanking exon 2 of the
murine Hif1a locus [51]. These mice were crossed with Tg(UBC-
Cre/ER
T2)1Ejb/J mice as described above to generate Hif1a
floxed-
UBC-Cre-ER
T2 mice and their corresponding controls, Hif1a
wt-
UBC-Cre-ER
T2 and Hif1a
floxed mice.
The mice were bred and housed in a specific pathogen free
(SPF) animal area of the animal facility at the Autonomous
University of Madrid (UAM). For gene inactivation, Vhl
wt-UBC-
Cre-ER
T2, Hif1a
wt-UBC-Cre-ER
T2 and the corresponding con-
trol males (10–5 weeks old) were fed ad libitum for ten days with
Teckland CRD TAM
400/CreER tamoxifen pellets (Harlan
Teklad), which contain 400 mg tamoxifen citrate/kg. Subsequent-
ly, they were returned to a diet of standard mouse chow (SafeH,
Augy, France) for an additional 10 days.
Reticulocyte counts and hematocrit measurement
The number of circulating or splenic reticulocytes was
determined by counting total blood or splenic cells respectively
followed by a flow cytometry analysis to determine the proportion
of reticulocytes identified as CD71 positive cells (using the anti-
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content (using the DNA dye Hoechst 33342) [52]. Similarly,
splenic mature erythrocytes were identified as CD71 negative and
Hoechst 33342 negative cells [52]. Hematocrit measurements
were performed using a hemocytometer (apparatus SYSMEX
KX-21N).
Quantitative real-time PCR analysis and primers
Mice were anaesthetized by intraperitoneal administration of
ketamine (KetolarH 50 mg/ml) and xylazine (RompunH 20 mg/
ml), and the tissues of interest were then removed and snap-frozen
in liquid nitrogen. Subsequently, the tissue was homogenized in
Trizol (Invitrogen) with two freeze/thaw cycles and total RNA was
isolated using the RNeasy RNA extraction kit (Qiagen). cDNA
was prepared by reverse transcription of RNA (1 mg) using
Improm-II reverse transcriptase (Promega), and polymerase chain
reaction (PCR) amplification was performed using a Power SYBR
Green PCR Master Mix kit (Applied Biosystems). The following
primer sets were used: mouse VHL (forward, 59-TCAGCCC-
TACCCGATCTTACC-39; reverse, 59-ATCCCTGAAGAGCC
AAAGATGA-39); mouse HIF-1a (forward, 59-CACCGATT-
CGCCATGGA-39; reverse, 59-TCGACGTTCAGAACTCATC-
TTTTT-39); rat HIF-1a (forward, 59-GTCCTGTGGTG-
ACTTGTCCTT-39; reverse, 59-TGGACTC TGATCATCT-
GACCAAA-39); mouse erythropoietin (EPO) (forward, 59-
TCATCTGCGACAGTCGAGTTCT-39; reverse, 59-TTTTC-
ACTCAGTCTGGGACCTTCT-39); rat erythropoietin (EPO)
(forward, 59-CAAGGAGGCAGAAAATGTCACA-39; reverse,
59-TTTCCAAGCGTAG AAGTTGACTTTG-39); mouse glu-
cose transporter 1 (GLUT1) (forward, 59-CGCAACGAGGA-
GAACC-39; reverse, 59-GCCGTG TTGACGATACC-39); hypo-
xanthine-guanine phosphoribosyltransferase (HPRT) (forward, 59-
GTTAAGCAGTACAGCCCCAAA-39; reverse, 59-AGGGCA-
TATCCAACAAC AAACTT-39). The data were analyzed using
StepOne Software version 2.0 (Applied Biosystems).
siRNA transfection
HL-1 cells were transfected with a siRNA targeting mouse HIF-
1a (50 nM, sc-44225: Santa Cruz) or a scrambled control siRNA
(sc-37007), using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. 24 hours after transfection the cells
were exposed to normoxic or hypoxic conditions for an additional
24 hours.
Statistical analysis
The data are presented as the mean 6 SEM. Statistical
significance was assessed using a two-tailed Student’s t-test in all
figures, except in Figures 6A and B in which a two-tailed paired t-
test was used.
Acknowledgments
The authors would like to thank Dr. L. del Peso, Dr. M.J. Calzada and
Victoria Rodriguez for critical reading of the manuscript. The HL-1
cardiomyocyte cell line was kindly provided by Dr. Wiliam C. Claycomb
(LSU Health Science Center, New Orleans, LA, USA).
Author Contributions
Conceived and designed the experiments: MM-M AE IS-A LA-A JA.
Performed the experiments: MM-M AE IS-A LA-A AV-V SV. Analyzed
the data: MM-M AE IS-A MOL JA. Contributed reagents/materials/
analysis tools: AO EB AV-V SV EF CF-C. Wrote the paper: MM-M AE
IS-A LA-A MOL JA.
References
1. Giaccia A, Siim BG, Johnson RS (2003) HIF-1 as a target for drug development.
Nat Rev Drug Discov 2: 803–811.
2. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. (2001) HIFalpha targeted
for VHL-mediated destruction by proline hydroxylation: implications for O2
sensing. Science 292: 464–468.
3. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, et al. (2001) Targeting
of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated
prolyl hydroxylation. Science 292: 468–472.
4. Bruick RK, McKnight SL (2001) A conserved family of prolyl-4-hydroxylases
that modify HIF. Science 294: 1337–1340.
5. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O’Rourke J, et al. (2001)
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases
that regulate HIF by prolyl hydroxylation. Cell 107: 43–54.
6. Semenza GL (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE
2007: cm8.
7. Eckardt KU, Kurtz A (2005) Regulation of erythropoietin production. Eur J Clin
Invest 35(Suppl 3): 13–19.
8. Fandrey J, Bunn HF (1993) In vivo and in vitro regulation of erythropoietin
mRNA: measurement by competitive polymerase chain reaction. Blood 81:
617–623.
9. Goldberg MA, Imagawa S, Strair RK, Bunn HF (1991) Regulation of the
erythropoietin gene in Hep 3B cells. Semin Hematol 28: 35–40; discussion 40-
31: .
10. Imagawa S, Goldberg MA, Bunn HF (1989) Regulation of the erythropoietin
gene. Adv Exp Med Biol 271: 75–85.
11. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, et al. (1997) Defective
placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc
Natl Acad Sci U S A 94: 9102–9107.
12. Feil R, Wagner J, Metzger D, Chambon P (1997) Regulation of Cre
recombinase activity by mutated estrogen receptor ligand-binding domains.
Biochem Biophys Res Commun 237: 752–757.
13. Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L, et al. (2007)
Deletion of the developmentally essential gene ATR in adult mice leads to age-
related phenotypes and stem cell loss. Cell Stem Cell 1: 113–126.
14. Casanova E, Fehsenfeld S, Lemberger T, Shimshek DR, Sprengel R, et al.
(2002) ER-based double iCre fusion protein allows partial recombination in
forebrain. Genesis 34: 208–214.
15. Forde A, Constien R, Grone HJ, Hammerling G, Arnold B (2002) Temporal
Cre-mediated recombination exclusively in endothelial cells using Tie2
regulatory elements. Genesis 33: 191–197.
16. Kiermayer C, Conrad M, Schneider M, Schmidt J, Brielmeier M (2007)
Optimization of spatiotemporal gene inactivation in mouse heart by oral
application of tamoxifen citrate. Genesis 45: 11–16.
17. Ma W, Tessarollo L, Hong SB, Baba M, Southon E, et al. (2003) Hepatic
vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in
mice with conditional inactivation of the VHL gene. Cancer Res 63: 5320–5328.
18. Young AP, Schlisio S, Minamishima YA, Zhang Q, Li L, et al. (2008) VHL loss
actuates a HIF-independent senescence programme mediated by Rb and p400.
Nat Cell Biol 10: 361–369.
19. Takeda K, Aguila HL, Parikh NS, Li X, Lamothe K, et al. (2008) Regulation of
adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111:
3229–3235.
20. Heinicke K, Baum O, Ogunshola OO, Vogel J, Stallmach T, et al. (2006)
Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to
hepatic, renal, neuronal, and muscular degeneration. Am J Physiol Regul Integr
Comp Physiol 291: R947–956.
21. Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, et al. (2003) Transgenic
mice overexpressing erythropoietin adapt to excessive erythrocytosis by
regulating blood viscosity. Blood 102: 2278–2284.
22. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, et al. (2007) Hypoxia-inducible
factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117:
1068–1077.
23. Zanjani ED, Ascensao JL, McGlave PB, Banisadre M, Ash RC (1981) Studies on
the liver to kidney switch of erythropoietin production. J Clin Invest 67:
1183–1188.
24. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A (2001) Regulation of glut1
mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.
J Biol Chem 276: 9519–9525.
25. Weidemann A, Kerdiles YM, Knaup KX, Rafie CA, Boutin AT, et al. (2009)
The glial cell response is an essential component of hypoxia-induced
erythropoiesis in mice. J Clin Invest 119: 3373–3383.
26. White SM, Constantin PE, Claycomb WC (2004) Cardiac physiology at the
cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle
cell structure and function. Am J Physiol Heart Circ Physiol 286: H823–829.
Cardiac HIF-Dependent Erythropoietin Expression
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e2258927. Mole DR, Ratcliffe PJ (2008) Cellular oxygen sensing in health and disease.
Pediatr Nephrol 23: 681–694.
28. Semenza GL (2002) Involvement of hypoxia-inducible factor 1 in human cancer.
Intern Med 41: 79–83.
29. Lei L, Mason S, Liu D, Huang Y, Marks C, et al. (2008) Hypoxia-inducible
factor-dependent degeneration, failure, and malignant transformation of the
heart in the absence of the von Hippel-Lindau protein. Mol Cell Biol 28:
3790–3803.
30. Boutin AT, Weidemann A, Fu Z, Mesropian L, Gradin K, et al. (2008)
Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 133:
223–234.
31. Traykova-Brauch M, Schonig K, Greiner O, Miloud T, Jauch A, et al. (2008)
An efficient and versatile system for acute and chronic modulation of renal
tubular function in transgenic mice. Nat Med 14: 979–984.
32. Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005) Ectopic expression of
Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial
tissues. Cell 121: 465–477.
33. Hsiao EC, Nguyen TD, Ng JK, Scott MJ, Chang WC, et al. (2011) Constitutive
Gs activation using a single-construct tetracycline-inducible expression system in
embryonic stem cells and mice. Stem Cell Res Ther 2: 11.
34. Katsantoni EZ, Anghelescu NE, Rottier R, Moerland M, Antoniou M, et al.
(2007) Ubiquitous expression of the rtTA2S-M2 inducible system in transgenic
mice driven by the human hnRNPA2B1/CBX3 CpG island. BMC Dev Biol 7:
108.
35. Mengozzi M, Latini R, Salio M, Sfacteria A, Piedimonte G, et al. (2006)
Increased erythropoietin production after myocardial infarction in mice. Heart
92: 838–839.
36. Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, et al. (2004) Cardiac myocyte-
specific HIF-1alpha deletion alters vascularization, energy availability, calcium
flux, and contractility in the normoxic heart. Faseb J 18: 1138–1140.
37. Jurgensen JS, Rosenberger C, Wiesener MS, Warnecke C, Horstrup JH, et al.
(2004) Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and
stromal cells of ischemic myocardium. Faseb J 18: 1415–1417.
38. Kim CH, Cho YS, Chun YS, Park JW, Kim MS (2002) Early expression of
myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-
activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ
Res 90: E25–33.
39. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, et al. (2001) HIF-
1 is expressed in normoxic tissue and displays an organ-specific regulation under
systemic hypoxia. Faseb J 15: 2445–2453.
40. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, et al.
(2003) Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell
populations of different organs. Faseb J 17: 271–273.
41. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, et al. (2008)
Complete loss of ischaemic preconditioning-induced cardioprotection in mice
with partial deficiency of HIF-1 alpha. Cardiovasc Res 77: 463–470.
42. Kapitsinou PP, Liu Q, Unger TL, Rha J, Davidoff O, et al. (2010) Hepatic HIF-
2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116:
3039–3048.
43. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, et al. (2004)
Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and
HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-
2alpha target gene in Hep3B and Kelly cells. Faseb J 18: 1462–1464.
44. Camici GG, Stallmach T, Hermann M, Hassink R, Doevendans P, et al. (2007)
Constitutively overexpressed erythropoietin reduces infarct size in a mouse
model of permanent coronary artery ligation. Methods Enzymol 435: 147–155.
45. Burger D, Xenocostas A, Feng QP (2009) Molecular basis of cardioprotection by
erythropoietin. Curr Mol Pharmacol 2: 56–69.
46. Ueda K, Takano H, Niitsuma Y, Hasegawa H, Uchiyama R, et al. (2010) Sonic
hedgehog is a critical mediator of erythropoietin-induced cardiac protection in
mice. J Clin Invest 120: 2016–2029.
47. Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, et al. (2005) Reversible
inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal
HIF-1. J Biol Chem 280: 41928–41939.
48. Ryou MG, Flaherty DC, Hoxha B, Sun J, Gurji H, et al. (2009) Pyruvate-
fortified cardioplegia evokes myocardial erythropoietin signaling in swine
undergoing cardiopulmonary bypass. Am J Physiol Heart Circ Physiol 297:
H1914–1922.
49. Eckle T, Kohler D, Lehmann R, El Kasmi K, Eltzschig HK (2008) Hypoxia-
inducible factor-1 is central to cardioprotection: a new paradigm for ischemic
preconditioning. Circulation 118: 166–175.
50. Haase VH, Glickman JN, Socolovsky M, Jaenisch R (2001) Vascular tumors in
livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.
Proc Natl Acad Sci U S A 98: 1583–1588.
51. Ryan HE, Lo J, Johnson RS (1998) HIF-1 alpha is required for solid tumor
formation and embryonic vascularization. Embo J 17: 3005–3015.
52. Chen SY, Wang Y, Telen MJ, Chi JT (2008) The genomic analysis of
erythrocyte microRNA expression in sickle cell diseases. PLoS One 3: e2360.
Cardiac HIF-Dependent Erythropoietin Expression
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22589